Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016

Lina van der Straten^{1

2}, Mark-David Levin², Otto Visser³, Eduardus F M Posthuma^{4

5}, Jeanette K Doorduijn⁶, Arnon P Kater⁷, Avinash G Dinmohamed^{1

6

8}

Affiliations

¹ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
² Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
³ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁴ Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands.
⁵ Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands.
⁶ Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁷ Department of Haematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
⁸ Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

Lina van der Straten et al. Br J Haematol. 2020 May.

. 2020 May;189(3):574-577.

doi: 10.1111/bjh.16397. Epub 2020 Jan 20.

Lina van der Straten^{1

2}, Mark-David Levin², Otto Visser³, Eduardus F M Posthuma^{4

5}, Jeanette K Doorduijn⁶, Arnon P Kater⁷, Avinash G Dinmohamed^{1

6

8}

¹ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
² Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
³ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁴ Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands.
⁵ Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands.
⁶ Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁷ Department of Haematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
⁸ Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

No abstract available

Keywords: cancer epidemiology; chronic lymphocytic leukaemia; population-based; registry; survival.

References

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. Journal of Clinical Pathology, 42, 567-584.
1. Brenner, H., Gondos, A. & Pulte, D. (2008) Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood, 111, 4916-4921. https://doi.org/10.1182/blood-2007-12-129379.
1. Dickman, P. & Adami, H. (2006) Interpreting trends in cancer patient survival. Journal of Internal Medicine, 260, 103-117. https://doi.org/10.1111/j.1365-2796.2006.01677.x.
1. Hallek, M. (2017) Role and timing of new drugs in CLL. Hematological Oncology, 35, 30-32. https://doi.org/10.1002/hon.2397.
1. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 5446-5456. https://doi.org/10.1182/blood-2007-06-093906.